Procurement of medicines, under the Framework Agreement for the supply of Medicines of group 4: blood - CP 2023/304

This tender, identified by reference LM 49/2026 and associated with framework agreement CP 2023/304, focuses on the procurement of medicines specifically from Group 4, which pertains to blood-related products. This procurement is conducted under an existing framework agreement, suggesting that pre-qualified suppliers have already been selected. The tender likely involves calling for specific orders or batches of these blood-related medicines. The objective is to ensure a consistent supply of these critical medical products. Potential bidders, likely existing framework agreement holders, will be invited to submit proposals for the specified quantities and types of medicines. Evaluation will likely focus on price competitiveness and adherence to the framework agreement's terms. This process ensures efficient and compliant acquisition of essential blood-related pharmaceuticals for healthcare needs.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,758.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.